ENTITY
Sanofi India

Sanofi India (SANL IN)

27
Analysis
Health CareIndia
Sanofi India Limited manufactures pharmaceuticals and chemicals. The Company has a worldwide presence, an extensive portfolio of prescription medicines, a portfolio of vaccines, major biological products, generics medicines, consumer healthcare, animal healthcare, and has a presence in both traditional and emerging markets.
more
Refresh
bullishMankind Pharma
12 Dec 2023 09:58

Mankind Pharma Placement - Its Expensive, but at Least It’s High Quality

A group of shareholders is looking to raise around US$600m via selling a 6.9% stake in Mankind Pharma. We had looked at the lockup release earlier.

Logo
447 Views
Share
bullishMankind Pharma
08 May 2023 12:45

Mankind Pharma IPO Trading - Strong Insti Demand Makes up for Retail Lag

Mankind Pharma  raised around US$527m in its upcoming India IPO. In this note, we talk about the demand updates and the trading dynamics.

Logo
356 Views
Share
bullishMankind Pharma
19 Apr 2023 12:18

Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside

Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.

Logo
394 Views
Share
19 Apr 2023 10:51

Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth

Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm...

Logo
435 Views
Share
bullishMankind Pharma
18 Apr 2023 17:04

Mankind Pharma Pre-IPO - RHP Updates - A Mixed Bag

Mankind Pharma  (MP) is now looking to raise around US$500m in its upcoming India IPO. In this note we talk about the updates from its recently...

Logo
344 Views
Share
x